BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 24014826)

  • 21. Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation.
    Cuijpers I; Papageorgiou AP; Carai P; Herwig M; Mügge A; Klein T; Hamdani N; Jones EAV; Heymans S
    J Cell Mol Med; 2021 Jan; 25(2):729-741. PubMed ID: 33295687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Davila A; Tian Y; Czikora I; Li J; Su H; Huo Y; Patel V; Robinson V; Kapuku G; Weintraub N; Bagi Z
    Circ Heart Fail; 2019 Aug; 12(8):e005762. PubMed ID: 31525084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
    Stolina M; Luo X; Dwyer D; Han CY; Chen R; Zhang Y; Xiong Y; Chen Y; Yin J; Shkumatov A; Ason B; Hale C; Véniant MM
    PLoS One; 2020; 15(8):e0231234. PubMed ID: 32804947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats.
    Nguyen ITN; Cramer MJ; Joles JA; Verhaar MC
    Am J Physiol Renal Physiol; 2023 Jul; 325(1):F73-F86. PubMed ID: 37227224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
    Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
    JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction.
    Miranda-Silva D; Wüst RCI; Conceição G; Gonçalves-Rodrigues P; Gonçalves N; Gonçalves A; Kuster DWD; Leite-Moreira AF; van der Velden J; de Sousa Beleza JM; Magalhães J; Stienen GJM; Falcão-Pires I
    Acta Physiol (Oxf); 2020 Mar; 228(3):e13378. PubMed ID: 31520455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise hemodynamics in patients with and without diastolic dysfunction and preserved ejection fraction after myocardial infarction.
    Andersen MJ; Ersbøll M; Bro-Jeppesen J; Gustafsson F; Hassager C; Køber L; Borlaug BA; Boesgaard S; Kjærgaard J; Møller JE
    Circ Heart Fail; 2012 Jul; 5(4):444-51. PubMed ID: 22705767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
    Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
    Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study.
    Leite S; Oliveira-Pinto J; Tavares-Silva M; Abdellatif M; Fontoura D; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1556-63. PubMed ID: 25862827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential changes in titin domain phosphorylation increase myofilament stiffness in failing human hearts.
    Kötter S; Gout L; Von Frieling-Salewsky M; Müller AE; Helling S; Marcus K; Dos Remedios C; Linke WA; Krüger M
    Cardiovasc Res; 2013 Sep; 99(4):648-56. PubMed ID: 23764881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.
    Paulus WJ; Zile MR
    Circ Res; 2021 May; 128(10):1451-1467. PubMed ID: 33983831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF.
    Summer G; Kuhn AR; Munts C; Miranda-Silva D; Leite-Moreira AF; Lourenço AP; Heymans S; Falcão-Pires I; van Bilsen M
    J Mol Cell Cardiol; 2020 Jul; 144():66-75. PubMed ID: 32422321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness.
    Falcão-Pires I; Hamdani N; Borbély A; Gavina C; Schalkwijk CG; van der Velden J; van Heerebeek L; Stienen GJ; Niessen HW; Leite-Moreira AF; Paulus WJ
    Circulation; 2011 Sep; 124(10):1151-9. PubMed ID: 21844073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction.
    Büttner P; Adams V; Werner S; Ossmann S; Besler C; Schwedhelm E; Thiele H
    ESC Heart Fail; 2022 Dec; 9(6):4348-4351. PubMed ID: 36043453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Old spontaneously hypertensive rats gather together typical features of human chronic left-ventricular dysfunction with preserved ejection fraction.
    Marzak H; Ayme-Dietrich E; Lawson R; Mokni W; Combe R; Becker J; Fertak LE; Champy MF; Monassier L
    J Hypertens; 2014 Jun; 32(6):1307-16. PubMed ID: 24786294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arginine metabolism and nitric oxide turnover in the ZSF1 animal model for heart failure with preserved ejection fraction.
    Büttner P; Werner S; Baskal S; Tsikas D; Adams V; Lurz P; Besler C; Knauth S; Bahls M; Schwedhelm E; Thiele H
    Sci Rep; 2021 Oct; 11(1):20684. PubMed ID: 34667218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction.
    Schauer A; Draskowski R; Jannasch A; Kirchhoff V; Goto K; Männel A; Barthel P; Augstein A; Winzer E; Tugtekin M; Labeit S; Linke A; Adams V
    ESC Heart Fail; 2020 Oct; 7(5):2123-2134. PubMed ID: 32710530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of exercise on passive myocardial stiffness in mice with diastolic dysfunction.
    Slater RE; Strom JG; Granzier H
    J Mol Cell Cardiol; 2017 Jul; 108():24-33. PubMed ID: 28476659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.